Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study

BACKGROUND: Biological therapies have revolutionized the treatment of severe asthma with type 2 inflammation. Although such treatments are very effective in reducing exacerbation and the dose of oral steroids, little is known about the persistence of symptoms in severe asthma patients treated with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilleminault, Laurent, Camus, Claire, Raherison-Semjen, Chantal, Capdepon, Audrey, Bourdin, Arnaud, Bonniaud, Philippe, Fry, Stéphanie, Devouassoux, Gilles, Blanc, François-Xavier, Pison, Christophe, Dupin, Clairelyne, Khayath, Naji, Courdeau, Joelle, Valcke-Brossollet, Judith, Nocent-Ejnaini, Cécilia, Rolland, Fabien, Lamandi, Carmen, Proust, Alain, Ozier, Anaig, Portel, Laurent, Gaspard, Wanda, Roux-Claude, Pauline, Beurnier, Antoine, Martinez, Stéphanie, Dot, Jean-Marc, Hennegrave, Florence, Vignal, Guillaume, Auvray, Etienne, Paleiron, Nicolas, Just, Nicolas, Miltgen, Jean, Russier, Maud, Olivier, Cécile, Taillé, Camille, Didier, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655663/
https://www.ncbi.nlm.nih.gov/pubmed/37966015
http://dx.doi.org/10.1177/17534666231202749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655663/
https://www.ncbi.nlm.nih.gov/pubmed/37966015
http://dx.doi.org/10.1177/17534666231202749

Ejemplares similares